ITM to Present Phase III COMPOSE Poster and Host Satellite

Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the...

Related Keywords

Germany ,United States ,Munich ,Bayern ,Uppsala ,Uppsala Lan ,Sweden ,Italy ,Garching ,Austria ,Vienna ,Wien ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Jaume Capdevila ,Ben Orzelek ,Julia Hofmann Svenja ,Wolfgang Weber ,Aldo Scarpa ,Heloisa Soares ,Uppsala University ,Hospital Trust Of Verona ,Hebron University Hospital ,University Of Utah ,European Neuroendocrine Tumor Society ,Technical University Of Munich ,Corporate Communications ,Department Of Pathology ,Oncology Department ,Symposium Program ,Department Of Nuclear Medicine ,Division Of Oncology ,Annual European Neuroendocrine Tumor Society ,Therapeutics Landscape ,Medical Oncology Department ,Endocrine Tumor Unit ,Endocrine Oncology ,Hospital Trust ,Nuclear Medicine ,Technical University ,Associate Professor ,Huntsman Cancer Hospital ,Radionuclide Therapy ,Technologies Munich ,Itm Isotope Technologies Munich Se ,Conference ,Nets2023 ,Satellite Symposium ,Gep Nets ,Theranostics ,